Delayed Yet Persistent Effects of Daily Risperidone on Activity in Developing Rats

Overview

Journal Behav Pharmacol

Specialties Pharmacology
Psychology
Social Sciences

Date 2016 Mar 10

PMID 26960160

Citations 6

Authors

Rachel M Stevens

Matthew A Gannon

Molly S Griffith

Mark E Bardgett

Affiliations

Soon will be listed here.

Abstract

Early-life administration of risperidone, the most widely used antipsychotic drug in children, leads to persistently elevated locomotor activity in adult rats. This study determined whether and when elevated locomotor activity emerges during developmental risperidone administration. Developing and adult rats were administered daily injections of risperidone (1.0 and 3.0 mg/kg) or vehicle for 4 weeks beginning at postnatal days 14 and 74, respectively. Starting with the first injection and every 7 days thereafter, locomotor activity was measured immediately after the injection and 20 min before the next day's injection. Activity was also recorded 1 week after the final injection. Risperidone markedly decreased locomotor activity in developing and adult rats immediately after injection. Within 24 h after their first injection, adult rats administered risperidone showed greater activity levels. In contrast, developing rats did not show compensatory hyperactivity until the beginning of the fourth week of risperidone administration. One week after the final risperidone injection, there was no evidence of hyperactivity in the adult rats maintained on risperidone, but developing rats administered risperidone, especially females, showed greater activity levels relative to vehicle-administered controls. In comparison with adult rats, the emergence of compensatory hyperactivity during long-term antipsychotic drug administration is delayed in developing rats, but persists after treatment cessation.

Citing Articles

Caudate nucleus volume in medicated and unmedicated patients with early- and adult-onset schizophrenia.

Andreou D, Jorgensen K, Nerland S, Calkova T, Morch-Johnsen L, Smelror R Sci Rep. 2024; 14(1):22755.

PMID: 39353988 PMC: 11445249. DOI: 10.1038/s41598-024-73322-x.

Early-life risperidone alters locomotor responses to apomorphine and quinpirole in adulthood.

Bardgett M, Griffith M, Robinson K, Stevens R, Gannon M, Knuth M Behav Brain Res. 2024; 473:115171.

PMID: 39094954 PMC: 11345744. DOI: 10.1016/j.bbr.2024.115171.

Does Intravitreal Dopamine Agonist and Antagonist Administration Have Effects on the Brain? An Experimental Study in Rats.

Kocak M, Ates O, Hacimuftuoglu A, Ates I, Tekin E, Ceylan O Eurasian J Med. 2022; 54(1):54-60.

PMID: 35307630 PMC: 9634906. DOI: 10.5152/eurasianjmed.2022.21288.

Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference.

Bardgett M, Downnen T, Crane C, Baltes Thompson E, Muncie B, Steffen S Neuropharmacology. 2020; 179:108276.

PMID: 32814089 PMC: 7572744. DOI: 10.1016/j.neuropharm.2020.108276.

The effects of amphetamine on working memory and locomotor activity in adult rats administered risperidone early in life.

Bardgett M, Crane C, Baltes Thompson E, Cox B, Downnen T Behav Brain Res. 2018; 362:64-70.

PMID: 30594546 PMC: 6448153. DOI: 10.1016/j.bbr.2018.12.044.

References

Nowycky M, Roth R . Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate. Naunyn Schmiedebergs Arch Pharmacol. 1977; 300(3):247-54. View

Kalverdijk L, Tobi H, van den Berg P, Buiskool J, Wagenaar L, Minderaa R . Use of antipsychotic drugs among Dutch youths between 1997 and 2005. Psychiatr Serv. 2008; 59(5):554-60. DOI: 10.1176/ps.2008.59.5.554. View

Arnt J . Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine. Eur J Pharmacol. 1995; 283(1-3):55-62. DOI: 10.1016/0014-2999(95)00292-s. View

Vitiello B, Correll C, van Zwieten-Boot B, Zuddas A, Parellada M, Arango C . Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol. 2009; 19(9):629-35. DOI: 10.1016/j.euroneuro.2009.04.008. View

Domino M, Swartz M . Who are the new users of antipsychotic medications?. Psychiatr Serv. 2008; 59(5):507-14. PMC: 2739805. DOI: 10.1176/ps.2008.59.5.507. View

Wiley J . Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats. Eur J Pharmacol. 2007; 578(2-3):216-21. PMC: 2693188. DOI: 10.1016/j.ejphar.2007.09.010. View

Tarazi F, Baldessarini R . Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain. Int J Dev Neurosci. 2000; 18(1):29-37. DOI: 10.1016/s0736-5748(99)00108-2. View

Kurre Olsen C, Brennum L, Kreilgaard M . Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics. Eur J Pharmacol. 2008; 584(2-3):318-27. DOI: 10.1016/j.ejphar.2008.02.005. View

Thacker S, Perna M, Ward J, Schaefer T, Williams M, Kostrzewa R . The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole. Eur J Neurosci. 2006; 24(7):2075-83. DOI: 10.1111/j.1460-9568.2006.05048.x. View

10.

Park K, Volkow N, Pan Y, Du C . Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D1 over D2 receptor signaling. J Neurosci. 2013; 33(40):15827-36. PMC: 3787501. DOI: 10.1523/JNEUROSCI.1935-13.2013. View

11.

Bardgett M, Franks-Henry J, Colemire K, Juneau K, Stevens R, Marczinski C . Adult rats treated with risperidone during development are hyperactive. Exp Clin Psychopharmacol. 2013; 21(3):259-67. PMC: 4041194. DOI: 10.1037/a0031972. View

12.

Andersen S, Rutstein M, Benzo J, Hostetter J, Teicher M . Sex differences in dopamine receptor overproduction and elimination. Neuroreport. 1997; 8(6):1495-8. DOI: 10.1097/00001756-199704140-00034. View

13.

Constantine R, Tandon R, McPherson M, Andel R . Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program. J Child Adolesc Psychopharmacol. 2011; 21(1):79-84. DOI: 10.1089/cap.2010.0068. View

14.

Izenwasser S . Differential effects of psychoactive drugs in adolescents and adults. Crit Rev Neurobiol. 2006; 17(2):51-67. PMC: 1752119. DOI: 10.1615/critrevneurobiol.v17.i2.10. View

15.

Cuomo V, Cagiano R, Coen E, Mocchetti I, Cattabeni F, Racagni G . Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol. Psychopharmacology (Berl). 1981; 74(2):166-9. DOI: 10.1007/BF00432686. View

16.

Samaha A, Reckless G, Seeman P, Diwan M, Nobrega J, Kapur S . Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery. Biol Psychiatry. 2008; 64(2):145-52. DOI: 10.1016/j.biopsych.2008.01.010. View

17.

Gleason M, Link Egger H, Emslie G, Greenhill L, Kowatch R, Lieberman A . Psychopharmacological treatment for very young children: contexts and guidelines. J Am Acad Child Adolesc Psychiatry. 2007; 46(12):1532-72. DOI: 10.1097/chi.0b013e3181570d9e. View

18.

Varela F, Der-Ghazarian T, Lee R, Charntikov S, Crawford C, McDougall S . Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats. J Psychopharmacol. 2013; 28(4):376-86. PMC: 5673084. DOI: 10.1177/0269881113504016. View

19.

Scalzo F, Spear L . Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats. Psychopharmacology (Berl). 1985; 85(3):271-6. DOI: 10.1007/BF00428186. View

20.

Muller P, Seeman P . Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology (Berl). 1978; 60(1):1-11. DOI: 10.1007/BF00429171. View